2017-2021 年美国商业处方集中美沙酮覆盖范围和事先授权要求的趋势。
Trends in Buprenorphine Coverage and Prior Authorization Requirements in US Commercial Formularies, 2017-2021.
机构信息
Department of Health Management and Policy, School of Public Health, University of Michigan, Ann Arbor.
Susan B. Meister Child Health Evaluation and Research Center, Department of Pediatrics, University of Michigan Medical School, Ann Arbor.
出版信息
JAMA Health Forum. 2022 Jul 8;3(7):e221821. doi: 10.1001/jamahealthforum.2022.1821. eCollection 2022 Jul.
Abstract
This cross-sectional study assesses buprenorphine coverage and prior authorization requirements in US commercial formulary data from 2017 to 2021.
摘要
本横断面研究评估了 2017 年至 2021 年美国商业处方数据中丁丙诺啡的覆盖范围和事先授权要求。
Zotero 插件